|
US3172546A
(en)
|
1961-05-19 |
1965-03-09 |
Union Carbide Corp |
Size reduction of biological substances
|
|
US4133814A
(en)
|
1975-10-28 |
1979-01-09 |
Eli Lilly And Company |
2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
|
|
IT1082518B
(it)
|
1977-01-25 |
1985-05-21 |
Fiat Spa |
Specchio a cristallo liquido da impiegare particolarmente come retrovisore per veicoli
|
|
US4380635A
(en)
|
1981-04-03 |
1983-04-19 |
Eli Lilly And Company |
Synthesis of acylated benzothiophenes
|
|
US4418068A
(en)
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
|
DK150008C
(da)
|
1981-11-20 |
1987-05-25 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
|
|
DE3312671A1
(de)
|
1983-04-08 |
1984-10-11 |
Heinz Finzer KG, 7880 Bad Säckingen |
Stanz- und biegewerkzeug-aggregat
|
|
IT1227626B
(it)
|
1988-11-28 |
1991-04-23 |
Vectorpharma Int |
Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
|
|
JP2642486B2
(ja)
|
1989-08-04 |
1997-08-20 |
田辺製薬株式会社 |
難溶性薬物の超微粒子化法
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
NZ248813A
(en)
|
1992-11-25 |
1995-06-27 |
Eastman Kodak Co |
Polymeric grinding media used in grinding pharmaceutical substances
|
|
US5298262A
(en)
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
|
US5336507A
(en)
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
|
ZA951497B
(en)
|
1994-03-02 |
1996-08-23 |
Lilly Co Eli |
Orally administerable pharmaceutical formulations
|
|
US5478705A
(en)
|
1994-05-25 |
1995-12-26 |
Eastman Kodak Company |
Milling a compound useful in imaging elements using polymeric milling media
|
|
US5500331A
(en)
|
1994-05-25 |
1996-03-19 |
Eastman Kodak Company |
Comminution with small particle milling media
|
|
US5631369A
(en)
|
1994-08-31 |
1997-05-20 |
Eli Lilly And Company |
Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
|
|
US5534270A
(en)
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
|
US5591456A
(en)
|
1995-02-10 |
1997-01-07 |
Nanosystems L.L.C. |
Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
IE80467B1
(en)
|
1995-07-03 |
1998-07-29 |
Elan Corp Plc |
Controlled release formulations for poorly soluble drugs
|
|
TW487582B
(en)
|
1995-08-11 |
2002-05-21 |
Nissan Chemical Ind Ltd |
Method for converting sparingly water-soluble medical substance to amorphous state
|
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
|
US6458811B1
(en)
|
1996-03-26 |
2002-10-01 |
Eli Lilly And Company |
Benzothiophenes formulations containing same and methods
|
|
US6713494B1
(en)
|
1996-08-28 |
2004-03-30 |
Eli Lilly And Company |
Amorphous benzothiophenes, methods of preparation and methods of use
|
|
WO1998035666A1
(en)
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
|
AU750125B2
(en)
|
1997-08-27 |
2002-07-11 |
Hexal Ag |
New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
|
|
US6165506A
(en)
|
1998-09-04 |
2000-12-26 |
Elan Pharma International Ltd. |
Solid dose form of nanoparticulate naproxen
|
|
JP2000095674A
(ja)
|
1998-09-22 |
2000-04-04 |
Sato Pharmaceutical Co Ltd |
口腔内崩壊時間短縮化錠剤の製造方法及び装置
|
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
US20040013613A1
(en)
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
EP1066825A1
(en)
|
1999-06-17 |
2001-01-10 |
The Procter & Gamble Company |
An anti-microbial body care product
|
|
DE19932157A1
(de)
|
1999-07-13 |
2001-01-18 |
Pharmasol Gmbh |
Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
PT1913939T
(pt)
|
2000-06-27 |
2017-07-19 |
Vectura Ltd |
Formulações para utilização em dispositivos inalatórios
|
|
JP4969761B2
(ja)
|
2000-08-31 |
2012-07-04 |
オバン・エナジー・リミテッド |
所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
|
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
EP1341521B1
(en)
|
2000-11-20 |
2009-01-07 |
Elan Pharma International Limited |
Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
|
PT2283817T
(pt)
|
2000-11-30 |
2016-08-22 |
Vectura Ltd |
Método de fabrico de partículas para utilização numa composição farmacêutica
|
|
WO2002045684A2
(en)
|
2000-12-06 |
2002-06-13 |
Pharmacia Corporation |
Rapidly dispersing pharmaceutical composition comprising effervescent agents
|
|
FI20010115A0
(fi)
|
2001-01-18 |
2001-01-18 |
Orion Corp |
Menetelmä nanopartikkelien valmistamiseksi
|
|
US20020187187A1
(en)
*
|
2001-04-21 |
2002-12-12 |
Toshimitsu Ohki |
Fast disintegrating meloxicam tablet
|
|
JP2005504266A
(ja)
|
2001-06-22 |
2005-02-10 |
エラン ファーマ インターナショナル，リミティド |
小規模ミルまたは微小流体工学を用いる高スループットスクリーニング法
|
|
DE60222160T2
(de)
|
2001-10-12 |
2008-06-12 |
Elan Pharma International Ltd., Athlone |
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
|
|
US7714006B1
(en)
|
2001-12-03 |
2010-05-11 |
King Pharmaceuticals Research & Development, Inc. |
Methods of modifying the bioavailability of metaxalone
|
|
US6407128B1
(en)
|
2001-12-03 |
2002-06-18 |
Elan Pharmaceuticals, Inc. |
Method for increasing the bioavailability of metaxalone
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
US6825161B2
(en)
|
2002-04-26 |
2004-11-30 |
Salvona Llc |
Multi component controlled delivery system for soap bars
|
|
AU2003276688A1
(en)
|
2002-09-02 |
2004-03-19 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical composition of metaxalone with enhanced oral bioavailability
|
|
JP2004099442A
(ja)
|
2002-09-04 |
2004-04-02 |
Nisshin Pharma Inc |
難溶性薬物含有製剤およびその製造方法
|
|
ATE541840T1
(de)
|
2002-09-30 |
2012-02-15 |
Gea Farmaceutisk Fabrik As |
Raloxifene-l-lactat oder ein hemihydrat davon, deren verwendungen, pharmazeutischen zusammensetzungen und herstellungsverfahren
|
|
DE10250081A1
(de)
*
|
2002-10-25 |
2004-05-13 |
Boehringer Ingelheim Vetmedica Gmbh |
Wasserlösliche Meloxicam Granulate
|
|
US20040173696A1
(en)
|
2002-12-17 |
2004-09-09 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
|
US20040121003A1
(en)
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
|
WO2004066981A1
(en)
|
2003-01-29 |
2004-08-12 |
Sun Pharmaceutical Industries Limited |
Oral controlled release pharmaceutical composition containing metaxalone as active agent
|
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
|
CN1819819B
(zh)
|
2003-05-07 |
2011-03-09 |
株式会社三养社 |
用于制备速熔片的高度可塑性颗粒
|
|
WO2005000273A1
(en)
|
2003-06-27 |
2005-01-06 |
Bioprogress S.P.A. |
Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2-pyrrolidone/vinyl-acetate
|
|
WO2005004915A2
(en)
|
2003-07-09 |
2005-01-20 |
Boehringer Ingelheim International Gmbh |
Compositions comprising meloxicam
|
|
US20050042177A1
(en)
|
2003-07-23 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel compositions of sildenafil free base
|
|
CA2534924A1
(en)
|
2003-08-08 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel metaxalone compositions
|
|
GB0320522D0
(en)
|
2003-09-02 |
2003-10-01 |
Glaxo Group Ltd |
Formulation
|
|
US9149440B2
(en)
|
2003-09-02 |
2015-10-06 |
University Of South Florida |
Nanoparticles for drug-delivery
|
|
DE602004006523T2
(de)
|
2003-10-01 |
2008-01-31 |
Debio Recherche Pharmaceutique S.A. |
Vorrichtung und verfahren zur herstellung von partikeln
|
|
CA2544627A1
(en)
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
WO2005087204A1
(en)
|
2004-03-08 |
2005-09-22 |
Spiridon Spireas |
Bioavailable solid dosage forms of metaxalone
|
|
CN101005828B
(zh)
|
2004-06-17 |
2012-01-11 |
维尔恩公司 |
用于经粘膜递送活性成分的包含粘膜粘附蛋白和所述活性物质的组合物
|
|
WO2006009419A1
(es)
|
2004-07-19 |
2006-01-26 |
Luis Cordova Boone |
Neumáticos con doble banda de rodamiento
|
|
KR20060024927A
(ko)
|
2004-09-15 |
2006-03-20 |
씨제이 주식회사 |
기계적 분쇄법에 의한 미크론 사이즈 인삼 분말의제조방법
|
|
WO2006041843A2
(en)
|
2004-10-04 |
2006-04-20 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical dosage form comprising meloxicam
|
|
CA2598204C
(en)
|
2004-11-09 |
2015-01-13 |
Board Of Regents, The University Of Texas System |
Stabilized hme composition with small drug particles
|
|
UA89513C2
(uk)
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
|
WO2006069419A1
(en)
|
2004-12-31 |
2006-07-06 |
Iceutica Pty Ltd |
Nanoparticle composition and methods for synthesis thereof
|
|
BRPI0610431A2
(pt)
|
2005-04-28 |
2012-10-23 |
Wyeth Corp |
composição farmacêutica, processo para preparar uma composição, cápsula, e, kit farmacêutico
|
|
JO3352B1
(ar)
|
2005-06-17 |
2019-03-13 |
Apr Applied Pharma Res Sa |
صيغ دايكلوفيناك وطرق استخدامه
|
|
NZ567627A
(en)
*
|
2005-09-30 |
2011-08-26 |
Boehringer Ingelheim Vetmed |
Granulation process for making a divisible tablet containing meloxicam
|
|
US20080292584A1
(en)
|
2005-10-14 |
2008-11-27 |
Mutual Pharmaceutical Company, Inc. |
Metaxalone products, method of manufacture, and method of use
|
|
JP2009519972A
(ja)
|
2005-12-15 |
2009-05-21 |
アキュスフィア， インコーポレイテッド |
粒子ベースの経肺投与または経鼻投与用製薬の製造方法
|
|
CA2631492A1
(en)
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for oral administration
|
|
DK1973527T3
(da)
|
2005-12-15 |
2010-02-01 |
Acusphere Inc |
Fremgangsmåder til fremstilling af partikelbaserede farmaceutiske formulationer til parenteral indgivelse
|
|
WO2007074477A2
(en)
|
2005-12-29 |
2007-07-05 |
Dabur Pharma Limited |
Metaxalone polymorphs
|
|
US8420122B2
(en)
|
2006-04-28 |
2013-04-16 |
Merck Sharp & Dohme Corp. |
Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
|
|
WO2007150075A2
(en)
|
2006-06-23 |
2007-12-27 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
|
|
WO2008000042A1
(en)
|
2006-06-30 |
2008-01-03 |
Iceutica Pty Ltd |
Methods for the preparation of biologically active compounds in nanoparticulate form
|
|
NZ573823A
(en)
|
2006-06-30 |
2012-05-25 |
Iceutica Pty Ltd |
Methods for the preparation of biologically active compounds in nanoparticulate form
|
|
CN100386312C
(zh)
|
2006-07-18 |
2008-05-07 |
上海世景国际贸易有限公司 |
2，4-二氨基苯磺酸及其盐的合成方法
|
|
WO2008013416A1
(en)
|
2006-07-27 |
2008-01-31 |
Amorepacific Corporation |
Process for preparing powder comprising nanoparticles of sparingly soluble drug
|
|
AR065802A1
(es)
|
2007-03-22 |
2009-07-01 |
Schering Corp |
Formulaciones de comprimidos que contienen sales de 8- [( 1- ( 3,5- bis- (trifluorometil) fenil) -etoxi ) - metil) -8- fenil -1, 7- diaza- spiro [ 4,5] decan -2- ona y comprimidos elaborados a partir de estas
|
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
活效製藥股份有限公司 |
微粉碎化有機化合物粒子之製法
|
|
AR067997A1
(es)
|
2007-08-24 |
2009-10-28 |
Novartis Ag |
Compuestos organicos
|
|
US20110086074A1
(en)
|
2008-06-02 |
2011-04-14 |
Dr. Reddy's Laboratories Ltd. |
Combinations of niacin and an oxicam
|
|
US8568696B2
(en)
|
2008-08-06 |
2013-10-29 |
Indiana Nanotech Llc |
Grinding method for the manipulation or preservation of calcium phosphate hybrid properties
|
|
AU2010239080B2
(en)
|
2009-04-24 |
2014-08-28 |
Iceutica Pty Ltd |
A novel formulation of diclofenac
|
|
AU2010239161B2
(en)
|
2009-04-24 |
2014-10-09 |
Iceutica Pty Ltd |
Production of encapsulated nanoparticles at commercial scale
|
|
NZ595902A
(en)
|
2009-04-24 |
2014-10-31 |
Iceutica Pty Ltd |
Method for the production of commercial nanoparticle and microparticle powders
|
|
EA201171284A1
(ru)
|
2009-04-24 |
2012-05-30 |
Айсьютика Пти Лтд. |
Новая технология изготовления напроксена
|
|
UA106231C2
(uk)
|
2009-04-24 |
2014-08-11 |
Айсьютика Пти Лтд |
Разова доза фармацевтичної композиції індометацину (варіанти)
|
|
KR101679522B1
(ko)
|
2009-04-24 |
2016-11-24 |
아이슈티카 피티와이 리미티드 |
생물학적 활성 물질의 용해 프로파일 개선방법
|
|
SG175768A1
(en)
*
|
2009-04-24 |
2011-12-29 |
Iceutica Pty Ltd |
A novel formulation of meloxicam
|
|
EP2421530B1
(en)
|
2009-04-24 |
2019-08-21 |
Iceutica Pty Ltd. |
Formulation of metaxalone
|
|
IL254370B2
(en)
|
2009-04-24 |
2023-12-01 |
Iceutica Pty Ltd |
Production of coated nanoparticles with a high particle volume
|
|
US8545879B2
(en)
*
|
2009-08-31 |
2013-10-01 |
Wilmington Pharmaceuticals, Llc |
Fast disintegrating compositions of meloxicam
|
|
CA2918908A1
(en)
|
2013-07-22 |
2015-01-29 |
Iceutica Inc. |
Formulation of metaxalone
|
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|